| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027060 |
| Receipt No. | R000031001 |
| Scientific Title | A Study on Ability to Detect Early Deterioration of Heart Failure with Respiratory Instability Telemonitoring - Aided by Innovative Tele-Monitoring Environment To Halt Ongoing Deterioration of Heart Failure: ITMETHOD-HF - |
| Date of disclosure of the study information | 2017/05/08 |
| Last modified on | 2019/05/02 (Ver. 7) |
| Basic information | ||
| Public title | A Study on Ability to Detect Early Deterioration of Heart Failure with Respiratory Instability Telemonitoring
- Aided by Innovative Tele-Monitoring Environment To Halt Ongoing Deterioration of Heart Failure: ITMETHOD-HF - |
|
| Acronym | ITMETHOD-HF | |
| Scientific Title | A Study on Ability to Detect Early Deterioration of Heart Failure with Respiratory Instability Telemonitoring
- Aided by Innovative Tele-Monitoring Environment To Halt Ongoing Deterioration of Heart Failure: ITMETHOD-HF - |
|
| Scientific Title:Acronym | ITMETHOD-HF | |
| Region |
|
|
| Condition | |||
| Condition | Chronic Heart Failure | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate that calculated Respiratory Stability Index (RSI) with remote monitoring in patients with chronic heart failure detects earlier deterioration of heart failure. |
| Basic objectives2 | Others |
| Basic objectives -Others | Usefullness of RSI as an early detection index |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Sensitivity of RSI
RSI levels of subjects clinically diagnosed as worsening heart failure by the investigator is decreased (1 day or more that the RSI is less than 20) prior to exacerbation. Specificity of RSI RSI levels of subjects clinically diagnosed stable heart failure by the investigator is not decreased less than 20 on the judgment day. |
| Key secondary outcomes | -Days of RSI decrease (less than 20) preceding exacerbation of heart failure
-RSI cutoff value -Malfunctions of home telemonitoring -Inter-day variations in RSI |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | To collect parameters using ITMETHOD remote monitoring system with noninvasive pressure sensor sheet and calculate RSI under home environment [ Time Frame: Intervention period (48 weeks) ] | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients with chronic heart failure under treatment (Including patients after heart transplantation or myoblast cell-sheet transplantation)
2. New York Heart Association (NYHA) class II, III and IV 3. Patients must have been hospitalized within 12 months or treated with increases in dose and/or changes in medications for exacerbation of heart failure. 4. Regular visits to our trial sites or affiliated hospitals 5. Daily internet access available in patients' bedrooms 6. Patients with 20 years of age or older at the time of their written consent 7. Patients who provided written informed consent |
|||
| Key exclusion criteria | 1. Patients who share a bed with other person or pets
2. Patients who are not considered able to measure overnight respiratory due to physical factors or lifestyle factors 3. Patients without spontaneous respiration 4. Patients with chronic respiratory failure or chronic obstructive pulmonary disease 5. Patients must not have started to use CPAP or ASV during sleep within a month 6. Patients whose QOL is limited by malignant tumor or other diseases 7. Patients who have sequela as the result of cerebrovascular disorder 8. Patients diagnosed with dementia 9. Patients who are inability to provide informed consent or doubted for his/her agreement 10. Any other patients who are determined as unsuitable for this study by the investigators |
|||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Osaka University Graduate School of Medicine | ||||||
| Division name | Cardiovascular surgery | ||||||
| Zip code | 565-0871 | ||||||
| Address | 2-2 Yamadaoka, Suita, Osaka | ||||||
| TEL | 06-6879-3154 | ||||||
| miyagawa@surg1.med.osaka-u.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Osaka University Graduate School of Medicine | ||||||
| Division name | Cardiovascular surgery | ||||||
| Zip code | 565-0871 | ||||||
| Address | 2-2 Yamadaoka, Suita, Osaka | ||||||
| TEL | 06-6879-3154 | ||||||
| Homepage URL | |||||||
| m-sakoda@surg1.med.osaka-u.ac.jp | |||||||
| Sponsor | |
| Institute | Osaka University Graduate School of Medicine, Cardiovascular surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Osaka University Clinical Research Review Committee |
| Address | 2-2 Yamadaoka, Suita, Osaka 565-0871 Japan |
| Tel | 06-6210-8296 |
| rinri@hp-crc.med.osaka-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 大阪大学医学部附属病院(大阪府)、射水市民病院(富山県)、JCHO高岡ふしき病院(富山県)、田附興風会医学研究所 北野病院(大阪府)、のぞみハートクリニック(東京都)、三重大学医学部附属病院(三重県)、ゆみのハートクリニック(大阪府) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 18 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031001 |